PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 24, 2025 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
PANTHERx® Rare Named to USA Today’s List of Top Workplaces for 2025
March 20, 2025 PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty...
Read More
PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen)
December 23, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
Neurocrine Biosciences, Inc. Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont)
December 20, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
Ascendis Pharma Selects PANTHERx® Rare for the Distribution of YORVIPATH® (palopegteriparatide)
December 6, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby™ (acoramidis)
November 25, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
